Inhibition of the calcineurin-NFAT signalling cascade in the treatment of heart failure

Recent Patents on Cardiovascular Drug Discovery

Volumn 4, Issue 3, 2009, Pages 180-186

  Panther, Franziska ^a   Williams, Tatjana ^a   Ritter, Oliver ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Calcineurin; Hypertrophy; NFAT; Nuclear import

Indexed keywords

ATROGIN 1; CALCINEURIN; CALPAIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLOSPORIN A; IMPORT BLOCKING PEPTIDE; KARYOPHERIN; KARYOPHERIN BETA; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

DRUG PROTEIN BINDING; GRAFT REJECTION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW;

EID: 76149092877     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489009789152276     Document Type: Review

References (78)

1. Reiter TA, Rusnak F. Is calcineurin a peroxide-specific sensor in T-lymphocytes? J Biol Inorg Chem 2002; 7: 823-834.
2. Rusnak F, Mertz P. Calcineurin: Form and function. Physiol Rev 2000; 80: 1483-1521.
3. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
4. 2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc Res 2004; 63: 450-457.
5. 2+, calcineurin and NF-AT. Cell 1999; 96: 611-614.
6. Ke H, Huai Q. Structures of calcineurin and its complexes with immunophilins-immunosuppressants. Biochem Biophys Res Commun 2003; 311: 1095-1102.
7. Halloran PF. Mechanism of action of the calcineurin inhibitors. Transplant Proc 2001; 33: 3067-3069.
8. Perrino BA, Wilson AJ, Ellison P, Clapp LH. Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit. Eur J Biochem 2002; 269: 3540-3548.
9. Molkentin JD. Calcineurin and beyond: Cardiac hypertrophic signaling. Circ Res 2000; 87: 731-738.
10. Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997; 12: 375-381.
11. Coghlan VM, Perrino BA, Howard M, et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995; 267: 108-111.
12. Lai MM, Burnett PE, Wolosker H, Blackshaw S, Snyder SH. Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem 1998; 273: 18325-18331.
13. Sun L, Youn HD, Loh C, Stolow M, He W, Liu JO. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 1998; 8: 703-711.
14. Scott, J.D., Coghlan, V.M., Howard, M.L., Gallatin, W.M.: US5807693 (1998).
15. Liu JO. Endogenous protein inhibitors of calcineurin. Biochem Biophys Res Commun 2003; 311: 1103-1109.
16. Dodge KL, Scott JD. Calcineurin anchoring and cell signaling. Biochem Biophys Res Commun 2003; 311: 1111-1115.
17. Taigen T, De Windt LJ, Lim HW, Molkentin JD. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000; 97: 1196-1201.
18. De Windt LJ, Lim HW, Bueno OF, et al. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2001; 98: 3322-3327.
19. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS. A protein encoded within the Down Syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 2000; 275: 8719-8725.
20. Fuentes JJ, Genesca L, Kingsbury TJ, et al. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 2000; 9: 1681-1690.
21. Burkard N, Becher J, Heindl C, Neyses L, Schuh K, Ritter O. Targeted proteolysis sustains calcineurin activation. Circulation 2005; 111: 1045-1053.
22. Hallhuber M, Burkard N, Wu R, et al. Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circ Res 2006; 99: 626-635.
23. Crawford, D.R.: WO03006619 (2003).
24. Carafoli E. Calcium signaling: A tale for all seasons. Proc Natl Acad Sci USA 2002; 99: 1115-1122.
25. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 2004; 322: 1178-1191.
26. Wilkins BJ, Molkentin JD. Calcineurin and cardiac hypertrophy: Where have we been? Where are we going? J Physiol 2002; 541: 1-8.
27. Arai, K.I., Liu, J.: US20046780597 (2004).
28. Jans DA, Xiao CY, Lam MH. Nuclear targeting signal recognition: A key control point in nuclear transport? Bioessays 2000; 22: 532-544.
29. Hogan PG, Rao A. Transcriptional regulation. Modification by nuclear export? Nature 1999; 398: 200-201.
30. Wu HY, Tomizawa K, Oda Y, et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 2004; 279: 4929-4940.
31. Poon IK, Jans DA. Regulation of nuclear transport: Central role in development and transformation? Traffic 2005; 6: 173-186.
32. Pemberton LF, Paschal BM. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 2005; 6: 187-198.
33. Rout MP, Aitchison JD. The nuclear pore complex as a transport machine. J Biol Chem 2001; 276: 16593-16596.
34. Ritter, O.: WO2007085455 (2007).
35. Rout MP, Aitchison JD, Magnasco MO, Chait BT. Virtual gating and nuclear transport: The hole picture. Trends Cell Biol 2003; 13: 622-628.
36. Nakielny S, Dreyfuss G. Import and export of the nuclear protein import receptor transportin by a mechanism independent of GTP hydrolysis. Curr Biol 1998; 8: 89-95.
37. Gorlich D, Seewald MJ, Ribbeck K. Characterization of Ran-driven cargo transport and the RanGTPase system by kinetic measurements and computer simulation. EMBO J 2003; 22: 1088-1100.
38. Gorlich D. Nuclear protein import. Curr Opin Cell Biol 1997; 9: 412-419.
39. Gorlich D, Dabrowski M, Bischoff FR, et al. A novel class of RanGTP binding proteins. J Cell Biol 1997; 138: 65-80.
40. Nigg EA. Nucleocytoplasmic transport: Signals, mechanisms and regulation. Nature 1997; 386: 779-787.
41. Goldfarb DS. Nuclear transport: Proliferating pathways. Curr Biol 1997; 7: R13-6.
42. Gorlich D, Mattaj IW. Nucleocytoplasmic transport. Science 1996; 271: 1513-1518.
43. Sweet DJ, Gerace L. A GTPase distinct from Ran is involved in nuclear protein import. J Cell Biol 1996; 133: 971-983.
44. Weis K, Dingwall C, Lamond AI. Characterization of the nuclear protein import mechanism using Ran mutants with altered nucleotide binding specificities. EMBO J 1996; 15: 7120-7128.
45. Moore MS, Blobel G. The GTP-binding protein Ran/TC4 is required for protein import into the nucleus. Nature 1993; 365: 661-663.
46. Melchior F, Paschal B, Evans J, Gerace L. Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol 1993; 123: 1649-1659.
47. Weis K. Nucleocytoplasmic transport: Cargo trafficking across the border. Curr Opin Cell Biol 2002; 14: 328-335.
48. Macara IG. Transport into and out of the nucleus. Microbiol Mol Biol Rev 2001; 65: 570-594, [table of contents].
49. Siomi MC, Eder PS, Kataoka N, Wan L, Liu Q, Dreyfuss G. Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. J Cell Biol 1997; 138: 1181-1192.
50. Rexach M, Blobel G. Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell 1995; 83: 683-692.
51. Zhang L, Torgerson TR, Liu XY, et al. Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc Natl Acad Sci USA 1998; 95: 9184-9189.
52. Frey, N., Olson, E.N.: US20040186275 (2004).
53. McKeon, F., Kayako, K., Ryeom, S.W.: US7396905 (2008).
54. Rao, A., Feske, S., Hogan, P., Gwack, Y.: WO2007081804 (2007).
55. Yang J, Rothermel B, Vega RB, et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 2000; 87: E61-68.
56. Rothermel BA, McKinsey TA, Vega RB, et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2001; 98: 3328-3333.
57. Hill JA, Rothermel B, Yoo KD, et al. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. J Biol Chem 2002; 277: 10251-10255.
58. Faulkner G, Pallavicini A, Comelli A, et al. FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J Biol Chem 2000; 275: 41234-41242.
59. Frey N, Olson EN. Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J Biol Chem 2002; 277: 13998-14004.
60. Frey N, Richardson JA, Olson EN. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci USA 2000; 97: 14632-14637.
61. Takada F, Vander Woude DL, Tong HQ, et al. Myozenin: An alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines. Proc Natl Acad Sci USA 2001; 98: 1595-1600.
62. Knoll R, Hoshijima M, Hoffman HM, et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002; 111: 943-955.
63. Frey N, Barrientos T, Shelton JM, et al. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med 2004; 10: 1336-1343.
64. Heineke J, Ruetten H, Willenbockel C, et al. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM proteincalcineurin signaling at the sarcomeric Z-disc. Proc Natl Acad Sci USA 2005; 102: 1655-1660.
65. Li HH, Kedar V, Zhang C, et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 2004; 114: 1058-1071.
66. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-1708.
67. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98: 14440-14445.
68. Roehrl MH, Kang S, Aramburu J, Wagner G, Rao A, Hogan PG. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc Natl Acad Sci USA 2004; 101: 7554-7559.
69. Bush E, Fielitz J, Melvin L, et al. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci USA 2004; 101: 2870-2875.
70. Harris CD, Ermak G, Davies KJ. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 2005; 62: 2477-2486.
71. Jeong D, Kim JM, Cha H, et al. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Circ Res 2008; 102: 711-719.
72. Bueno OF, van Rooij E, Molkentin JD, Doevendans PA, De Windt LJ. Calcineurin and hypertrophic heart disease: Novel insights and remaining questions. Cardiovasc Res 2002; 53: 806-821.
73. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999; 285: 2129-2133.
74. Pu WT, Ma Q, Izumo S. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circ Res 2003; 92: 725-731.
75. Cunningham MD, Cleaveland J, Nadler SG. An intracellular targeted NLS peptide inhibitor of karyopherin alpha:NF-kappa B interactions. Biochem Biophys Res Commun 2003; 300: 403-407.
76. Torgerson TR, Colosia AD, Donahue JP, Lin YZ, Hawiger J. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J Immunol 1998; 161: 6084-6092.
77. 2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy. Cardiology 2007; 107: 281-290.
78. Rana OR, Saygili E, Meyer C, et al. Regulation of nerve growth factor in the heart: The role of the calcineurin-NFAT pathway. J Mol Cell Cardiol 2009; 46: 568-578.